Clinical Trial Update: 18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis [NA]

View source ↗

Summary

This document provides an update on a clinical trial evaluating an 18F-labeled picolinamide PET imaging agent for diagnosing melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• 18F-labeled picolinamide PET imaging tracer (18F-picolinamide)

Snippet

Sponsor: Xijing Hospital | Conditions: Melanoma | NA | Status: UNKNOWN